Tissue inhibitor of metalloproteinase (TIMP)-1: the TIMPed balance of matrix metalloproteinases in the central nervous system
about
The innate immune system in demyelinating diseaseActivity dependent CAM cleavage and neurotransmissionGlucocorticoids in the management of peritumoral brain edema: a review of molecular mechanismsAstrocytes in multiple sclerosis: a product of their environmentHIV-1, methamphetamine and astrocytes at neuroinflammatory CrossroadsEndothelin-Mediated Changes in Gene Expression in Isolated Purified Rat Retinal Ganglion CellsNeuroprotective effects of overexpressing tissue inhibitor of metalloproteinase TIMP-1.Interferon stimulated exonuclease gene 20 kDa links psychiatric events to distinct hepatitis C virus responses in human immunodeficiency virus positive patients.Alterations of matrix metalloproteinases in the healthy elderly with increased risk of prodromal Alzheimer's disease.T-cell production of matrix metalloproteinases and inhibition of parasite clearance by TIMP-1 during chronic Toxoplasma infection in the brain.Extracellular regulated kinase 1/2 signaling is a critical regulator of interleukin-1β-mediated astrocyte tissue inhibitor of metalloproteinase-1 expression.The interplay of cell-cell and cell-matrix interactions in the invasive properties of brain tumorsCCAAT/enhancer binding protein β expression is increased in the brain during HIV-1-infection and contributes to regulation of astrocyte tissue inhibitor of metalloproteinase-1.A dual role for microglia in promoting tissue inhibitor of metalloproteinase (TIMP) expression in glial cells in response to neuroinflammatory stimuliBrain distribution and elimination of recombinant human TIMP-1 after cerebral ischemia and reperfusion in rats.Screening for new biomarkers for subcortical vascular dementia and Alzheimer's diseaseDisruption in the Blood-Brain Barrier: The Missing Link between Brain and Body Inflammation in Bipolar Disorder?Brain protection using autologous bone marrow cell, metalloproteinase inhibitors, and metabolic treatment in cerebral ischemia.Toxoplasma on the brain: understanding host-pathogen interactions in chronic CNS infection.An apolipoprotein E4 fragment affects matrix metalloproteinase 9, tissue inhibitor of metalloproteinase 1 and cytokine levels in brain cell lines.TIMP-1 deficiency leads to lethal partial hepatic ischemia and reperfusion injury.Extracellular Matrix Modulation Is Driven by Experience-Dependent Plasticity During Stroke Recovery.HIV-1, methamphetamine and astrocyte glutamate regulation: combined excitotoxic implications for neuro-AIDS.Nitric oxide-mediated regulation of β-amyloid clearance via alterations of MMP-9/TIMP-1Low brain DHA content worsens sensorimotor outcomes after TBI and decreases TBI-induced Timp1 expression in juvenile ratsWhole brain radiation-induced cognitive impairment: pathophysiological mechanisms and therapeutic targetsNewborn screening for autism: in search of candidate biomarkers.TIMP-1/MMP-9 imbalance in brain edema in rats with fulminant hepatic failure.Myeloperoxidase inactivates TIMP-1 by oxidizing its N-terminal cysteine residue: an oxidative mechanism for regulating proteolysis during inflammation.Novel role of TGF-beta in differential astrocyte-TIMP-1 regulation: implications for HIV-1-dementia and neuroinflammationMMP-independent role of TIMP-1 at the blood brain barrier during viral encephalomyelitis.Glial response during cuprizone-induced de- and remyelination in the CNS: lessons learned.Temporal course of changes in gene expression suggests a cytokine-related mechanism for long-term hippocampal alteration after controlled cortical impact.Astrocytes in the tempest of multiple sclerosis.Integrated Analysis of Expression Profile Based on Differentially Expressed Genes in Middle Cerebral Artery Occlusion Animal Models.Destination Brain: the Past, Present, and Future of Therapeutic Gene Delivery.Protective effect of carbamazepine on kainic acid-induced neuronal cell death through activation of signal transducer and activator of transcription-3.Hepatic apoptosis can modulate liver fibrosis through TIMP1 pathway.A novel mechanism of tissue inhibitor of metalloproteinases-1 activation by interleukin-1 in primary human astrocytes.Human aqueous humor levels of transforming growth factor-β2: Association with matrix metalloproteinases/tissue inhibitors of matrix metalloproteinases.
P2860
Q24597958-09FBCAA9-AAB5-4D68-9844-770CCC14E99BQ26796243-C6F635E0-2EFA-4526-9892-EDB01C35E171Q28075735-70B4F24F-2206-4126-988D-2C43B9E60DD0Q28282324-4B45B9DA-573B-4CBA-8432-67CFB33CA5F8Q28392199-71BF9587-8D02-4D43-BBB3-0CC15889D7A2Q30370132-23903BCF-638B-43D0-A597-AAC18F9349F9Q33657719-BB4B523C-E7A8-4560-9B3F-8847902479E4Q33968365-012AFB51-FF2D-4557-9A03-972227D3DC8BQ34058311-98C2B396-7179-43F9-9C3E-224E2F7341FCQ34509768-E552886D-952C-4E6A-973D-F44B5008DE08Q34607184-BE99B6F2-8CA2-4C05-BBDF-321FC0018351Q35021389-2C8B73C9-3814-448C-B3C3-C84F210131BAQ35038078-FBED124D-67F8-4657-BE7A-DE93DE7BFA57Q35061225-6B2099C4-DD18-4BBF-82CB-CF08553529ABQ35354948-55B6B534-629C-4D78-A39D-CF24D730D067Q35428298-3F9CBD69-FC24-4E60-94B3-5AE4CAB1168FQ35649716-7F49EA63-866A-427C-850E-05C3596DE38FQ35652254-2D0DC5B5-5810-4280-95B5-0ADE403F31E8Q35876115-C767E300-EE25-469B-B835-7B363CDE4AF2Q35981432-8F46C437-9C94-436F-ACD2-C30281B9607BQ36067201-930E726A-B09D-47F1-AE6F-AE25F9F53B8DQ36307057-5A5C26B2-7F8F-49DB-B8A6-52790E1EC0A2Q36634233-B2FA319D-586F-4634-996D-CF594C87E963Q36735832-ABB6B52C-2518-4D5B-A5C3-2D550D9D5BB0Q37120253-BAF16E0B-5742-440B-AABC-EDF46CED57BAQ37145380-93839643-424A-4B0D-8D56-0B822C8AFE50Q37167836-E5F28993-C751-495F-A756-7C88F931E156Q37184471-13D165C2-CABF-4B5A-B9F4-9F3BA36C377CQ37265070-373F3C60-3F59-42EA-818F-43783A7519DDQ37287836-9CAF54F9-818C-4FF7-87DA-4E21FAD2853BQ37342611-1CF43897-396B-4A67-B223-E941C107D0F5Q37634375-1FB37A22-D6A7-4273-B157-1FE685C52F0EQ37653743-32D622D6-645F-4640-9422-C53D48990B16Q37858667-FE98DA07-EAEF-4D3A-BFBD-5C07598FE041Q38447000-52856B29-C907-4E2B-A626-B76492372359Q38761724-07690A6D-EDF5-4490-85D7-2D5A5D44526DQ43439841-8525D9CC-1DF0-49E8-9AF6-D37157CAF5DBQ44213281-FD441007-32D8-4F51-8E3E-F297FC1E2292Q44923694-B5952806-0982-4A60-9ED2-5FE1C557669FQ47127174-A7DE96C4-143A-44A9-A47D-213CF195CA8C
P2860
Tissue inhibitor of metalloproteinase (TIMP)-1: the TIMPed balance of matrix metalloproteinases in the central nervous system
description
2003 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2003
@ast
im Dezember 2003 veröffentlichter wissenschaftlicher Artikel
@de
scientific article (publication date: 15 December 2003)
@en
vedecký článok (publikovaný 2003/12/15)
@sk
vědecký článek publikovaný v roce 2003
@cs
wetenschappelijk artikel (gepubliceerd op 2003/12/15)
@nl
наукова стаття, опублікована в грудні 2003
@uk
مقالة علمية (نشرت في 15-12-2003)
@ar
name
Tissue inhibitor of metallopro ...... in the central nervous system
@ast
Tissue inhibitor of metallopro ...... in the central nervous system
@en
Tissue inhibitor of metallopro ...... in the central nervous system
@nl
type
label
Tissue inhibitor of metallopro ...... in the central nervous system
@ast
Tissue inhibitor of metallopro ...... in the central nervous system
@en
Tissue inhibitor of metallopro ...... in the central nervous system
@nl
prefLabel
Tissue inhibitor of metallopro ...... in the central nervous system
@ast
Tissue inhibitor of metallopro ...... in the central nervous system
@en
Tissue inhibitor of metallopro ...... in the central nervous system
@nl
P2860
P3181
P356
P1476
Tissue inhibitor of metallopro ...... in the central nervous system
@en
P2093
Anuja Ghorpade
Jessica Gardner
P2860
P3181
P356
10.1002/JNR.10835
P407
P577
2003-12-15T00:00:00Z